Another study of 105 patients with glioblastoma showed that extent of resection, MGMT promoter methylation status and YKL-40 expression by immunohistochemistry were the most important prognostic factors in newly diagnosed glioblastomas (21). The gene discussed is MGMT; the disease is glioblastoma.